NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 38 filers reported holding NRX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,387 | -82.3% | 9,181 | -67.1% | 0.00% | – |
| Q2 2023 | $13,521 | +135110.0% | 27,936 | +88.2% | 0.00% | – |
| Q1 2023 | $10 | +42.9% | 14,842 | +143.2% | 0.00% | – |
| Q4 2022 | $7 | -99.9% | 6,102 | -52.8% | 0.00% | – |
| Q3 2022 | $10,000 | +400.0% | 12,936 | +219.2% | 0.00% | – |
| Q2 2022 | $2,000 | -84.6% | 4,053 | -21.1% | 0.00% | – |
| Q1 2022 | $13,000 | +1200.0% | 5,134 | +2244.3% | 0.00% | – |
| Q4 2021 | $1,000 | -90.0% | 219 | -78.7% | 0.00% | – |
| Q3 2021 | $10,000 | +900.0% | 1,026 | +683.2% | 0.00% | – |
| Q2 2021 | $1,000 | – | 131 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $41,714 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 230,700 | $152,054 | 0.00% |
| Virtu Financial LLC | 46,210 | $30 | 0.00% |
| United Asset Strategies, Inc. | 18,300 | $12,062 | 0.00% |
| HBK Sorce Advisory LLC | 29,230 | $19,266 | 0.00% |
| UBS Group AG | 18,611 | $12,265 | 0.00% |
| NewEdge Advisors, LLC | 2,125 | $1,401 | 0.00% |
| OSAIC HOLDINGS, INC. | 27,225 | $17,933 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 30,000 | $19,770 | 0.00% |
| WELLS FARGO & COMPANY/MN | 5,309 | $3,500 | 0.00% |